PRESS RELEASES
SANOFI AT A GLANCE

Press releases

February 3, 2023
Press releases
Press Release : Strong sales performance and double digit EPS growth marking the achievement of the 2022 profitability milestone
January 30, 2023
Press releases
Press Release:  Dupixent® (dupilumab) approved by European Commission as the first and only targeted medicine indicated for eosinophilic esophagitis
January 27, 2023
Press releases
Press Release: Dupixent® (dupilumab) recommended for expanded EU approval by the CHMP to treat children as young as six months old with severe atopic dermatitis
January 25, 2023
Press releases
Press Release: NEJM publishes once-weekly efanesoctocog alfa Phase 3 data demonstrating its potential to transform the treatment landscape for people with hemophilia A
January 11, 2023
Press releases
Press Release: Sanofi Ventures announces multi-year capital commitment from Sanofi, increasing evergreen fund to $750M
ALL PRESS RELEASES

Contact the Media team

Global Media Relations Department
54 rue La Boétie
75008 Paris FRANCE
+33 (0)1 53 77 46 46 • mr@sanofi.com

ALL THE CONTACTS

You are a journalist and have a question about Sanofi, please contact the Global Media Relations team: please note the contact details are only for Medias. For any other request, please call the switchboard: +33 1 53 77 40 00

Email Alerts

Resources

Sanofi at a glance

Publications

Our Integrated Report 2021

Annual Report on Form 20-F 2021

Half Year 2022 Financial Report

ALL THE PUBLICATIONS

Press Statements

Find out more about all our press statements